Kudipudi Srinivas

Prof. Dr. Kudipudi Srinivas

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2014 in International Journal of Proteomics
Verified
Journal Article
Open access
PDF file
VRV. Srinivasa Rao
V. Srinivasa Rao
KSKudipudi Srinivas
Kudipudi Srinivas
GSG. N. Sujini
G. N. Sujini
GKG. N. Sunand Kumar
G. N. Sunand Kumar
Protein-protein interaction plays key role in predicting the protein function of target protein and drug ability of molecules. The majority of genes and proteins realize resulting phenotype functions as a set of interactions. Thein vitroandin vivomethods like affinity purification, Y2H (yeast 2 hybrid), TAP (tandem affinity purification), and so forth have their own limitations like cost, time, and so forth, and the resultant data sets are noisy and have more false positives to annotate the function of drug molecules. Thus,in silicomethods which include sequence-based approaches, structure-based approaches, chromosome proximity, gene fusion,in silico2 hybrid, phylogenetic tree, phylogenetic profile, and gene expression-based approaches were developed. Elucidation of protein interaction networks also contributes greatly to the analysis of signal transduction pathways. Recent developments have also led to the construction of networks having all the protein-protein interactions using computational methods for signaling pathways and protein complex identification in specific diseases.

5 June 2023 in Multimedia Tools and Applications
Verified
Journal Article
Open access
PDF file
KSKudipudi Srinivas
Kudipudi Srinivas
RSR. Gagana Sri
R. Gagana Sri
KPK. Pravallika
K. Pravallika
NKNISHITHA KOMMINENI
NISHITHA KOMMINENI
DPDr SUBBA RAO POLAMURI
Dr SUBBA RAO POLAMURI
The Corona Virus was first started in the Wuhan city, China in December of 2019. It belongs to the Coronaviridae family, which can infect both animals and humans. The diagnosis of coronavirus disease-2019 (COVID-19) is typically detected by Serology, Genetic Real-Time reverse transcription–Polymerase Chain Reaction (RT-PCR), and Antigen testing. These testing methods have limitations like limited sensitivity, high cost, and long turn-around time. It is necessary to develop an automatic detection system for COVID-19 prediction. Chest X-ray is a lower-cost process in comparison to chest Computed tomography (CT). Deep learning is the best fruitful technique of machine learning, which provides useful investigation for learning and screening a large amount of chest X-ray images with COVID-19 and normal. There are many deep learning methods for prediction, but these methods have a few limitations like overfitting, misclassification, and false predictions for poor-quality chest X-rays. In order to overcome these limitations, the novel hybrid model called “Inception V3 with VGG16 (Visual Geometry Group)” is proposed for the prediction of COVID-19 using chest X-rays. It is a combination of two deep learning models, Inception V3 and VGG16 (IV3-VGG). To build the hybrid model, collected 243 images from the COVID-19 Radiography Database. Out of 243 X-rays, 121 are COVID-19 positive and 122 are normal images. The hybrid model is divided into two modules namely pre-processing and the IV3-VGG. In the dataset, some of the images with different sizes and different color intensities are identified and pre-processed. The second module i.e., IV3-VGG consists of four blocks. The first block is considered for VGG-16 and blocks 2 and 3 are considered for Inception V3 networks and final block 4 consists of four layers namely Avg pooling, dropout, fully connected, and Softmax layers. The experimental results show that the IV3-VGG model achieves the highest accuracy of 98% compared to the existing five prominent deep learning models such as Inception V3, VGG16, ResNet50, DenseNet121, and MobileNet.

19 May 2020
Verified
Book Chapter
Closed access
PDF file
DPDr SUBBA RAO POLAMURI
Dr SUBBA RAO POLAMURI
KSKudipudi Srinivas
Kudipudi Srinivas
AMA. Krishna Mohan
A. Krishna Mohan

24 August 2010 in Medical Hypotheses
Verified
Journal Article
Closed access
GSGumpeny R. Sridhar
Gumpeny R. Sridhar
ARAllam Appa Rao
Allam Appa Rao
KSKudipudi Srinivas
Kudipudi Srinivas
GNGumpeny Nirmala
Gumpeny Nirmala
GLGumpeny Lakshmi
Gumpeny Lakshmi
THThota Hanuman
Thota Hanuman

28 July 2020 in Arabian Journal for Science and Engineering
Verified
Journal Article
Closed access
PDF file
DPDr SUBBA RAO POLAMURI
Dr SUBBA RAO POLAMURI
KSKudipudi Srinivas
Kudipudi Srinivas
AMA. Krishna Mohan
A. Krishna Mohan

6 December 2013 in Bioinformation
Verified
Journal Article
Open access
VRV Srinivasa Rao
V Srinivasa Rao
KSKudipudi Srinivas
Kudipudi Srinivas
GKGn Sunand Kumar
Gn Sunand Kumar
GSGn Sujin
Gn Sujin
Alzheimer's disease (AD) is the most common form of dementia. It is the sixth leading cause of death in old age people. Despite recent advances in the field of drug design, the medical treatment for the disease is purely symptomatic and hardly effective. Thus there is a need to understand the molecular mechanism behind the disease in order to improve the drug aspects of the disease. We provided two contributions in the field of proteomics in drug design. First, we have constructed a protein-protein interaction network for Alzheimer's disease reviewed proteins with 1412 interactions predicted among 969 proteins. Second, the disease proteins were given confidence scores to prioritize and then analyzed for their homology nature with respect to paralogs and homologs. The homology persisted with the mouse giving a basis for drug design phase. The method will create a new drug design technique in the field of bioinformatics by linking drug design process with protein-protein interactions via signal pathways. This method can be improvised for other diseases in future.